NIAID launched the Phase II study of the vaccine against the virus Zeka
The National Institute of Allergy and Infectious Diseases USA (NIAID) launched the second phase of the clinical trials of the vaccine against the virus Zika, informs Reuters. In clinical trials in the United States, Puerto Rico, Brazil, Peru, Costa Rica, Panama and...
April 3rd, 2017